Search results
Author(s):
Ivan Wong
,
Michael Chiang
,
Angus Shing Fung Chui
,
et al
Added:
9 months ago
Author(s):
Jack Tan Wei Chieh
,
Huay Cheem Tan
,
Michael Kang-Yin Lee
,
et al
Added:
7 months ago
Congenital Mitral Valve Anomaly
Author(s):
Ma Liza R Quetulio
,
Giselle Ann E Llabado
,
Anne Marie Kathryn I Pineda
,
et al
Added:
1 year ago
Article
Author(s):
Jonathan Yap
,
Kentaro Hayashida
,
Michael Kang-Yin Lee
,
et al
Added:
7 months ago
Author(s):
Rena Winant
,
Sunu Budhi Raharjo
,
Rina Ariani
,
et al
Added:
10 months ago
Author(s):
Arvinjay A Bautista
,
Danilo S Kuizon
Added:
1 year ago
Author(s):
Baravan Al-Kassou
Added:
2 months ago
CRT 25 - Insights on the progression risk in patients with mild to moderate aortic stenosis (AS) show that there was no significant difference in progression rates between mild and moderate AS. However, moderate AS patients had significantly higher mortality rates than mild AS patients at one- and two-year follow ups. The study also suggests that elevated phosphate levels and elevated…
View more
Author(s):
Stephan Baldus
Added:
6 months ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,…
View more
Author(s):
Firas Zahr
Added:
6 months ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP…
View more
Author(s):
Reynald Evan R Tugade
,
Monica D Reyes-Sindiong
,
Fatima R Collado
Added:
6 months ago